For patients with systemic lupus erythematosus (SLE), iberdomide at a higher dose is superior to placebo for the rate of response indicating reduction in disease activity, according to a study published in the March 17 issue ...
Mar 17, 2022
0
15
(HealthDay)—Legalization of recreational cannabis is not associated with changes in health care utilization, as measured by length of stay or health care costs, according to a study published in the May issue of BMJ Open.
May 16, 2019
0
1
(HealthDay)—In an expert panel consensus, published online Nov. 12 in the Journal of the American Academy of Dermatology, opioid-prescribing guidelines are presented for common dermatologic procedures.
Nov 26, 2019
0
2
For patients with high folate receptor α (FRα)-positive ovarian cancer, a first-in-class antibody-drug conjugate targeting FRα, mirvetuximab soravtansine-gynx (MIRV), shows a significant benefit over chemotherapy, according ...
Dec 7, 2023
0
0
A bill to further restrict abortion in Oklahoma and another to make embryonic stem cell research illegal both cleared a House committee on Wednesday, despite concerns from a doctor on the panel.
Feb 4, 2015
1
7
Ashton Glover Gatewood decided to give medical school a second try after learning about a new campus designed for Indigenous students like herself.
Nov 2, 2023
0
18
A new Spanish peanut variety that packs high levels of healthful oleic acid has been released by U.S. Department of Agriculture (USDA) scientists and university cooperators. The new variety, called OLé, could provide producers ...
Feb 25, 2015
0
7
Blue Bell Creameries knew there was listeria in one of the company's plants as far back as March 2013, according to a government investigation. But the company didn't issue any recalls or shut down its production until after ...
May 7, 2015
0
7
(HealthDay)—In its latest ruling on capital punishment, the U.S. Supreme Court on Monday upheld the use of a controversial drug that had raised concerns that it didn't perform as intended—to put an inmate into a coma-like ...
Jun 29, 2015
0
4
Consumer products giant Johnson & Johnson is appealing an Oklahoma judge's $572 million order against the company and its subsidiaries for helping fuel the state's opioid crisis.
Sep 26, 2019
0
0
